NUPLAZID® is an FDA-approved treatment for hallucinations and delusions associated with Parkinson's disease psychosis.
Find support in even more ways
Downloadable resources
PD-related Hallucinations and Delusions Fact Sheet
NUPLAZID Fact Sheet
Symptom Discussion Guide
Treatment Discussion Guide
Acadia Connect®
Enroll in Acadia Connect
Acadia Connect Patient and Caregiver Brochure
Beverly & Bud's story
Six years after being diagnosed with PD, Beverly started to experience hallucinations and delusions related to her Parkinson's. In this video, Beverly and her husband, Bud, share their story—from the first signs of Beverly's symptoms to treatment with NUPLAZID.
These stories represent the experiences of people living with PD-related hallucinations and delusions. The opinions expressed are their own, and individual experiences may vary. Always speak with your healthcare provider.
Find a specialist near you
Do you need a doctor for PD-related hallucinations and delusions? Use the tool below to find one near you. A specialist can help you understand what you or your loved one is experiencing and explore treatment options.
Note to healthcare providers: If your practice is currently listed within the results of the Specialist Finder Tool, and you would like to opt out, please click here.
Hallucinations and delusions may be more common than you think
Get more information about PD-related hallucinations and delusions
IMPORTANT SAFETY INFORMATION and INDICATION
What is the most important information I should know about NUPLAZID?
Medicines like NUPLAZID can raise the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia).
NUPLAZID is not approved for the treatment of patients with dementia who experience psychosis unless their hallucinations and delusions are related to Parkinson’s disease.
Who should not take NUPLAZID?
- Do not take NUPLAZID if you have had an allergic reaction to any of the ingredients in NUPLAZID. Allergic reactions have included rash, hives, swelling of the tongue, mouth, lips, or face, throat tightness, and shortness of breath.
- Do not take NUPLAZID if you have certain heart conditions that change your heart rhythm. It is important to talk to your healthcare provider about this possible side effect. Call your healthcare provider if you feel a change in your heartbeat.
What other warnings should I know about NUPLAZID?
- QT Interval Prolongation: NUPLAZID may increase the risk of changes to your heart rhythm. This risk may increase if NUPLAZID is taken with certain other medications known to prolong the QT interval. Tell your healthcare provider about all the medicines you take or have recently taken.
Please also see What is the most important information I should know about NUPLAZID?
What medicine might interact with NUPLAZID?
- Tell your healthcare provider about all the medicines you take. Other medicines may affect how NUPLAZID works. Some medicines should not be taken with NUPLAZID. Your healthcare provider can tell you if it is safe to take NUPLAZID with your other medicines. Do not start or stop any medicines while taking NUPLAZID without talking to your healthcare provider first.
What are the common side effects of NUPLAZID?
- The common side effects of NUPLAZID include swelling in the legs or arms, nausea, confusion, hallucination, constipation, and changes to normal walking. These are not all the possible side effects of NUPLAZID. For more information, ask your healthcare provider about this medicine.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088. You can also call Acadia Pharmaceuticals Inc. at 1‑844‑4ACADIA (1‑844‑422‑2342).
Indication
NUPLAZID is a prescription medicine used to treat hallucinations and delusions associated with Parkinson’s disease psychosis.
How should I take NUPLAZID?
The recommended dose of NUPLAZID is one 34 mg capsule once per day, taken by mouth, with or without food.
NUPLAZID is available as 34 mg capsules and 10 mg tablets.
Please read the full Prescribing Information, including Boxed WARNING.